| Obesity |
1 |
1 |
| Weight Management |
0 |
0.99 |
| Weight Loss |
0 |
0.98 |
| Type 2 Diabetes Mellitus |
0 |
0.7 |
| Body Mass Index |
0 |
0.27 |
| Health Care Reform |
0 |
0.2 |
| Child |
0 |
0.19 |
| Lipids Management |
0 |
0.19 |
| Pediatric Nephrology |
0 |
0.17 |
| Alabama |
0 |
0.15 |
| Canada |
0 |
0.15 |
| Diabetes Research |
0 |
0.15 |
| Outpatient Clinic |
0 |
0.15 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Revenue and Practice Management |
0 |
0.11 |
| Patient Safety |
0 |
0.1 |
| Cardiometabolic Risk Factors |
0 |
0.09 |
| Adverse Effects |
0 |
0.08 |
| C-Reactive Protein (CRP) |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Insurance |
0 |
0.08 |
| Match |
0 |
0.08 |
| Medical Life |
0 |
0.08 |
| Metabolism |
0 |
0.08 |
| Hypertension |
0 |
0.07 |
| Sleep Apnea |
0 |
0.07 |
| Sleep Disorders |
0 |
0.07 |
| Obstructive Sleep Apnea |
0 |
0.06 |
| Biomarker |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Cardiovascular disease |
0 |
0.04 |
| Chronic Disease |
0 |
0.04 |
| Dehydration |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Dyslipidemia |
0 |
0.04 |
| Endocrinology |
0 |
0.04 |
| Exercise |
0 |
0.04 |
| Genetics |
0 |
0.04 |
| Genomic Medicine |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Long-Term Care |
0 |
0.04 |
| Massachusetts |
0 |
0.04 |
| Mobility |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Plasma |
0 |
0.04 |
| Prediabetes |
0 |
0.04 |
| Quality of Life |
0 |
0.04 |
| Sleep |
0 |
0.04 |
| Spain |
0 |
0.04 |
| Triglycerides |
0 |
0.04 |
| Virginia |
0 |
0.04 |
| Washington |
0 |
0.04 |